< Back to previous page
Researcher
Thomas Vanassche
- Disciplines:Cardiac and vascular medicine, Molecular and cell biology
Affiliations
- Centre for Molecular and Vascular Biology (Division)
Member
From19 Aug 2010 → Today - Cardiology (Division)
Member
From1 Oct 2009 → 18 Aug 2010
Projects
1 - 10 of 13
- Multigene thrombophilia testing in patients with venous thromboembolismFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- Mechanical cardiac unloading with micro-axial flow pumps: post-implantation effects on remodelling and bleeding/thrombosisFrom16 Sep 2021 → TodayFunding: FWO fellowships
- Targeting Immunothrombosis in Staphylococcus Aureus Infections and EndocarditisFrom1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Investigating the role of neutrophil extracellular traps in the failing heartFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting Immunothrombosis in Staphylococcus aureus infections and endocarditisFrom1 Oct 2020 → TodayFunding: BOF - projects
- Calming the storm: treating hypercoagulability and hyperinflammation in patients with COVID-19From22 May 2020 → 21 May 2021Funding: FWO thematic call for applied research
- Neutrophil extracellular traps in cardiac fibrosis - Peptidylarginine deiminase 4 and neutrophil extracellular traps in chronic inflammation and cardiac fibrosisFrom1 Oct 2019 → 6 Oct 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Thromboinflammation in Cardiovascular DiseasesFrom1 Aug 2019 → 20 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Activation of the contact pathway of coagulation in cardiovascular diseasesFrom1 Oct 2017 → 30 Sep 2019Funding: BOF - Other initiatives
Publications
11 - 20 of 176
- Edoxaban use in the context of dental procedures: analysis from the EMIT-AF/VTE database(2023)
Authors: Thomas Vanassche
- Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis(2023)
Authors: Lorenz Van der Linden, Thomas Vanassche, Lucas Van Aelst, Peter Verhamme
Pages: 2369 - 2376 - Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support(2023)
Authors: Charlotte Van Edom, Dieter Dauwe, Thomas Vanassche, Dirk Vlasselaers, Bart Meyns
Pages: 1707 - 1720 - The use of glucagon-like-peptide-1 receptor agonist in the cardiology practice(2023)
Authors: Chantal Mathieu, Thomas Vanassche
Pages: 552 - 564 - Emicizumab for acquired haemophilia A: A case series(2023)
Authors: Veerle Labarque, Kathelijne Peerlinck, Peter Verhamme, Thomas Vanassche
Pages: 1049 - 1055 - INFLAMMATION MARKERS AS POTENTIAL MEDIATORS FOR THE ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND OBESITY(2023)
Authors: Thomas Vanassche, Lucas Van Aelst, Peter Verhamme
Pages: E102 - E102 - Proteomics and Metabolomics for Prevention, Diagnosis, and Mechanistic Insights in Cardiovascular Disease(2023)
Authors: Dongmei Wei, Zhenyu Zhang, Thomas Vanassche, Lucas Van Aelst
- From bad to worse: the shortage of fibrinolytics(2023)
Authors: Lorenz Van der Linden, Thomas Vanassche, Robin Lemmens, Peter Verhamme
Pages: 125 - 126 - Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study(2023)
Authors: Dongmei Wei, Peter Verhamme, Lucas Van Aelst, Thomas Vanassche
- Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis(2023)
Authors: Christophe Vandenbriele, Peter Verhamme, Thomas Vanassche
Pages: 490 - 498